Preferred Name |
Ibritumomab Tiuxetan |
|
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00026874 |
|
Database_Cross_Reference |
RXNORM:262323 NDFRT:N0000148737 NDFRT:N0000010134 PDQ:CDR0000038483 MMSL:17128 NCI_FDA:4Q52C550XK NCI_NCI-GLOSS:CDR0000574728 MTHSPL:4Q52C550XK MSH:C422802 VANDF:4021301 PDQ:CDR0000043080 DRUGBANK:DB00078 NDDF:009576 CHV:0000051938 SNOMEDCT_US:410951004 SNOMEDCT_US:385548008 NCI:C29981 |
|
label |
Ibritumomab Tiuxetan |
|
MCID |
MC00307376 |
|
PMOID |
PMO:00026874 |
|
prefixIRI |
pmo:PMO_00026874 |
|
prefLabel |
Ibritumomab Tiuxetan |
|
Synonym |
ibritumomab tiuxetan Ibritumomab tiuxetan Ibritumomab tiuxetan (substance) IBRITUMOMAB TIUXETAN mAb Murine (IGG1) Anti P19437 (CD20_MOUSE) ibritumomab tiuxetan [Chemical/Ingredient] Ibritumomab tiuxetan (product) |
|
Tree Number |
T6.4.13.6.1.1.1 |
|
subClassOf |
Create mapping